Cashu | News | CTMX

HomeWatchlistNewsSignalsPicks

DJI

+0.78%

SPX

+0.70%

IXIC

+0.52%

FTSE

+0.59%

N225

0.00%

AXJO

+0.56%

HomeWatchlistNewsSignalsPicks

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Privacy Policy
Terms of Use

Instagram YouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Latest CytomX Therapeutics News

Nano-Cap CytomX Therapeutics Stock Surges On Heels Of Cancer Data Report

Feature Image for interests on Benzinga, Biotech, Briefs, Ctmx from benzinga.com

finance.yahoo.com

Autolus Therapeutics announces appointment of Matthias Will, M.D. as Chief Development Officer

Feature Image for interests on Autoimmune Diseases, Biopharmaceutical Company, Cell Therapies, Chief Development Officer from finance.yahoo.com

finance.yahoo.com

CytomX Therapeutics to Present at Upcoming September Investor Conferences

Feature Image for interests on Cytomx Therapeutics, Healthcare, Inc., Investor Conferences from finance.yahoo.com

finance.yahoo.com

CytomX Therapeutics Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Feature Image for interests on Analyst Estimates, Cytomx Therapeutics, Earnings Per Share, Healthcare from finance.yahoo.com

finance.yahoo.com

CytomX Therapeutics: Q2 Earnings Snapshot

Feature Image for interests on California-Based Company, Ctmx, Cytomx Therapeutics Inc., Healthcare from finance.yahoo.com

finance.yahoo.com

CytomX Therapeutics, Inc. (NASDAQ:CTMX) is definitely on the radar of institutional investors who own 47% of the company

Feature Image for interests on Analyst Forecasts, Cytomx Therapeutics, Healthcare, Inc. from finance.yahoo.com

finance.yahoo.com

CytomX Therapeutics to Present at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference

Feature Image for interests on Cytomx Therapeutics, Healthcare, Inc., Sean Mccarthy from finance.yahoo.com

CytomX Therapeutics to Present at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference

CytomX Therapeutics Promotes Chris Ogden to Chief Financial Officer

finance.yahoo.com

Shareholders in CytomX Therapeutics (NASDAQ:CTMX) are in the red if they invested five years ago

Feature Image for interests on Earnings Per Share, Healthcare, Share Price, Stock from finance.yahoo.com

Latest Cashu News

CytomX Therapeutics: Leading the Charge in Innovative Cancer Treatment with Probody Technology

CytomX Therapeutics: Pioneering Cancer Care with Innovative Probody Technology

Stocks

Health Care

ctmx

CytomX Therapeutics

CTMX

+0.01 (+0.50%)

2.01

USD

At close at May 16, 20:41 UTC